Trial NCT00504491

View at ClinicalTrials.gov 
Org. Study IDs: GELLC-2
Secondary IDs: 2007-003097-26

Last trial update was posted on 2011-12-30

MeSH Interventions

Alemtuzumab Rituximab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

Chronic Lymphocytic Leukaemia Patients Relapsed With Purines Therapy Patients Resistant to a Purine Analogous

Stopping Reasons

IMP new owner decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID